Compare KOD & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOD | ZENV |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | Brazil |
| Employees | 121 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 16.5M |
| IPO Year | 2018 | 2021 |
| Metric | KOD | ZENV |
|---|---|---|
| Price | $23.19 | $0.60 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $28.29 | N/A |
| AVG Volume (30 Days) | 503.1K | ★ 610.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.60 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $0.25 |
| 52 Week High | $31.18 | $2.16 |
| Indicator | KOD | ZENV |
|---|---|---|
| Relative Strength Index (RSI) | 41.55 | 47.96 |
| Support Level | $21.19 | $0.25 |
| Resistance Level | $29.17 | $1.00 |
| Average True Range (ATR) | 1.70 | 0.07 |
| MACD | -0.35 | 0.03 |
| Stochastic Oscillator | 8.59 | 58.32 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.